2024-11-22 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Report

This report analyzes UnitedHealth Group Inc. (UNH) based on the provided data.

**1. Performance Relative to S&P 500 (VOO):**

UnitedHealth Group Inc. is a diversified healthcare company offering a range of products and services.  The cumulative return of UNH is 205.27%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 126.85%. The difference in cumulative returns is 78.42%, placing UNH in the 49.52nd percentile of its historical performance relative to the S&P 500 based on the provided max/min range.

**Alpha and Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha | Beta | Cap(B) |
|------------|--------|--------|-------|-------|--------|
| 2015-2017  | 129.6% | 12.2%  | 91.2% | 0.9   | 202.9  |
| 2016-2018  | 123.9% | 18.6%  | 91.6% | 0.9   | 229.3  |
| 2017-2019  | 90.5%  | 21.0%  | 38.8% | 0.9   | 270.6  |
| 2018-2020  | 66.1%  | 35.3%  | 18.8% | 1.1   | 322.7  |
| 2019-2021  | 116.2% | 35.3%  | 16.1% | 1.0   | 462.1  |
| 2020-2022  | 89.2%  | 35.3%  | 65.6% | 0.9   | 487.9  |
| 2021-2023  | 57.0%  | 16.3%  | 22.1% | 0.5   | 484.5  |
| 2022-2024  | 23.7%  | 18.8%  | -5.9% | 0.5   | 552.6  |

The CAGR (Compound Annual Growth Rate) shows significant historical growth, while the MDD (Maximum Drawdown) indicates periods of market correction.  Alpha values generally show outperformance over the benchmark (except 2022-2024), and Beta values suggest a relatively low correlation with the overall market, although fluctuating over time.


**2. Recent Price Movement:**

* Closing Price: $597.27
* 5-Day Moving Average: $591.33
* 20-Day Moving Average: $586.26
* 60-Day Moving Average: $584.30

The price is above all three moving averages, suggesting a positive short-term trend.

**3. Technical Indicators:**

* RSI: 59.76 (Neither overbought nor oversold)
* PPO: 0.0 (Neutral)
* 20-Day Relative Strength Change: +7.93 (Short-term upward momentum)

The indicators show a relatively neutral to slightly positive outlook. The current price ($597.27) is not significantly above recent averages to suggest a sudden price surge.  The expected return of 36.6% over the long term (2+ years) represents a significant outperformance compared to the S&P 500.

**4. Recent Earnings and Outlook:**

| Date       | EPS    | Revenue          |
|------------|--------|-------------------|
| 2024-11-04 | 6.56   | $100.82 B        |
| 2024-08-09 | 4.58   | $98.86 B        |
| 2024-05-09 | -1.53  | $99.80 B        |
| 2023-11-06 | 6.31   | $92.36 B        |
| 2024-11-04 | 6.31   | $92.36 B        | *(Duplicate entry)*

The most recent earnings (November 4th, 2024) show a strong EPS of 6.56, exceeding the previous quarter's performance.  There is a significant jump in revenue, while there are fluctuations in reported EPS throughout the year. Further analysis comparing these numbers to analyst expectations is needed for a complete evaluation.


**6. Financial Information:**

**1) Revenue and Profitability:**

| Quarter     | Revenue    | Profit Margin |
|-------------|------------|---------------|
| 2024-09-30  | $99.18B    | 21.56%        |
| 2024-06-30  | $97.86B    | 21.52%        |
| 2024-03-31  | $98.78B    | 22.26%        |
| 2023-12-31  | $93.25B    | 22.33%        |
| 2023-09-30  | $91.36B    | 24.51%        |

Revenue is relatively stable and shows consistent profitability.  Profit margins are generally healthy, although they have fluctuated slightly throughout the year.

**2) Capital and Profitability:**

| Quarter     | Equity     | ROE    |
|-------------|------------|--------|
| 2024-09-30  | $94.53B    | 6.41%  |
| 2024-06-30  | $89.36B    | 4.72%  |
| 2024-03-31  | $86.69B    | -1.63% |
| 2023-12-31  | $88.76B    | 6.15%  |
| 2023-09-30  | $84.49B    | 6.91%  |

Equity shows a general upward trend, and ROE (Return on Equity) is generally positive, indicating efficient use of shareholder capital.  However, there's a notable negative ROE in Q1 2024 that requires further investigation.


**7. News and Recent Issues:**

*(This section requires access to real-time news sources like Shacknews and Finbold to provide specific information on recent earnings news, analyst opinions, and market outlook.  Please provide links or data from these sources for a complete analysis.)*

**8. Overall Analysis:**

UNH has significantly outperformed the S&P 500 over the long term.  Recent earnings show strong revenue and generally positive profitability, although some quarter-to-quarter fluctuations are observed. Technical indicators are mostly neutral, but the recent positive momentum is promising. The long-term outlook, indicated by the high expected return, is positive.  However, a more detailed analysis of the most recent earnings report against analyst expectations and a review of recent news and market sentiment is crucial for a complete assessment.


**9. Disclaimer:** This report is for informational purposes only and does not constitute financial advice.  Investing in the stock market involves risk, and past performance does not guarantee future results.  Conduct thorough research and consider consulting a financial advisor before making any investment decisions.
